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Abstract 
 
Recently, kidney stone formation has been recognized as a MetS-related disease 
[1-4]. The aims of the present study were to elucidate a possible mechanism of kidney 
crystal formation by using a metabolic syndrome (MetS) mouse model and to assess the 
effectiveness of adiponectin treatment for the prevention of kidney crystals. Further, we 
performed genome-wide expression analyses for investigating novel genetic 
environmental changes. Wild-type (+/+) mice showed no kidney crystal formation, 
whereas ob/ob mice showed crystal depositions in their renal tubules. However, this 
deposition was remarkably reduced by adiponectin. Expression analysis of genes 
associated with MetS-related kidney crystal formation identified 259 genes that were 
>2.0-fold up-regulated and 243 genes that were <0.5-fold down-regulated. Gene 
Ontology (GO) analyses revealed that the up-regulated genes belonged to the 
categories of immunoreaction, inflammation, and adhesion molecules and that the 
down-regulated genes belonged to the categories of oxidative stress and lipid 
metabolism. Expression analysis of adiponectin-induced genes related to crystal 
prevention revealed that the numbers of up- and down-regulated genes were 154 and 
190, respectively. GO analyses indicated that the up-regulated genes belonged to the 
categories of cellular and mitochondrial repair, whereas the down-regulated genes 
belonged to the categories of immune and inflammatory reactions and apoptosis. The 
results of this study provide compelling evidence that the mechanism of kidney crystal 
formation in the MetS environment involves the progression of an inflammation and 
immunoresponse, including oxidative stress and adhesion reactions in renal tissues. 
This is the first report to prove the preventive effect of adiponectin treatment for kidney 
crystal formation by renoprotective activities and inhibition of inflammation and 
apoptosis. 
 
References 
1. Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of 
kidney stones. JAMA 293: 455–462.  
2. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K (2004) The 
metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation 
of insulin resistance. Kidney Int 65: 386–392.  
3. Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T et al. (1999) Essential 
arterial hypertension and stone disease. Kidney Int 55: 2397–2406. 
4. Yasui T, Itoh Y, Bing G, Okada A, Tozawa K et al. (2007) Aortic calcification in 
urolithiasis patients. Scand J Urol Nephrol 41: 419–421. 
